Goprelto
NDC 70839-359, cocaine hydrochloride, solution, from LXO US Inc..
- Product NDC
- 70839-359
- Status
- Listed
- Labeler
- LXO US Inc.
- Dosage form
- SOLUTION
- Route
- NASAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA209963
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/70839-359 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- COCAINE HYDROCHLORIDE40 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70839-359-04 | 70839035904 | 1 BOTTLE, GLASS in 1 CARTON (70839-359-04) / 4 mL in 1 BOTTLE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0f897764-fe30-090a-e063-6294a90af106
Use it
Look up 70839-359 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70839-359 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70839-359. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.